Related Experiment Video
Updated: Jun 21, 2026

Extended 78% Hepatectomy in a Mouse Surgical Model
Published on: May 24, 2024
Long-term outcome following pediatric liver transplantation for metabolic disorders
Terrell Stevenson1, Maria T Millan, Karen Wayman
1Department of Surgery, Stanford University, Stanford, CA, USA.
Insights
Pediatric liver transplantation offers excellent survival and improved growth for children with metabolic disorders. While psychomotor development enhances, cognitive skills remain in the low-normal range post-transplant.
Area of Science:
- Pediatric Hepatology
- Metabolic Disorders
- Transplantation Immunology
Background:
- Metabolic disorders can lead to severe liver dysfunction in children.
- Liver transplantation is a potential treatment, but long-term outcomes require evaluation.
Purpose of the Study:
- To assess long-term survival, growth, and neurodevelopmental outcomes in children with metabolic disorders following liver transplantation.
Main Methods:
- Retrospective chart review of 54 children with metabolic disorders evaluated between 1989-2005.
- Analysis of presenting symptoms, transplant details, survival rates, metabolic parameters, and developmental assessments.
Main Results:
- 33 children underwent liver transplantation (12 with combined liver-kidney).
- Excellent patient survival (100%) and allograft survival (92-100%) at a median 3.6-year follow-up.
- Improved weight Z scores and normal BMI; significant psychomotor development gains (p < 0.01), but mental skills remained low-normal.
Conclusions:
- Liver or combined liver-kidney transplantation is associated with excellent long-term survival in pediatric metabolic disorders.
- Transplantation improves growth and psychomotor development, though cognitive function may lag.
- Outcomes comparable to biliary atresia patients for psychomotor development, but lower for mental skills.
Abstract:
In order to determine long-term outcome, including survival, growth and development, following liver transplantation in children with metabolic disorders, we retrospectively reviewed charts of 54 children with metabolic disorders evaluated from 1989-2005 for presenting symptoms, transplantation timing and indications, survival, metabolic parameters, growth, and development. Thirty-three patients underwent liver transplantation (12 received combined liver-kidney transplants) at a median age of 21 months. At a median follow-up of 3.6 yr, patient survival was 100%, and liver and kidney allograft survival was 92%, and 100%, respectively. For the group as a whole, weight Z scores improved and body mass index at follow-up was in the normal range. Two yr post-transplantation, psychomotor development improved significantly (p < 0.01), but mental skills did not; however, both indices were in the low-normal range of development. When compared to patients with biliary atresia, children with metabolic disorders showed significantly lower mental developmental scores at one and two yr post-transplantation (p < 0.05), but psychomotor developmental scores were not significantly different. We conclude that, in patients with metabolic disorders meeting indications for transplantation, liver transplantation or combined liver-kidney transplantation (for those with accompanying renal failure) is associated with excellent long-term survival, improved growth, and improved psychomotor development.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Inborn Errors of Metabolism
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management